1. Home
  2. TECX vs KRNY Comparison

TECX vs KRNY Comparison

Compare TECX & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$28.61

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

Logo Kearny Financial Corp

KRNY

Kearny Financial Corp

N/A

Current Price

$9.78

Market Cap

603.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
KRNY
Founded
2019
1884
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
618.9M
603.5M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
TECX
KRNY
Price
$28.61
$9.78
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$75.20
$9.25
AVG Volume (30 Days)
197.5K
614.6K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
5.45%
EPS Growth
40.70
35.71
EPS
N/A
0.57
Revenue
N/A
$2,580,000.00
Revenue This Year
N/A
$3.89
Revenue Next Year
N/A
$17.52
P/E Ratio
N/A
$17.21
Revenue Growth
N/A
36.00
52 Week Low
$14.39
$6.23
52 Week High
$39.53
$10.24

Technical Indicators

Market Signals
Indicator
TECX
KRNY
Relative Strength Index (RSI) 39.61 51.49
Support Level $27.53 $9.43
Resistance Level $31.39 $10.24
Average True Range (ATR) 2.27 0.24
MACD -0.57 -0.03
Stochastic Oscillator 5.14 42.57

Price Performance

Historical Comparison
TECX
KRNY

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About KRNY Kearny Financial Corp

Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.

Share on Social Networks: